ArticleFrontiers in oncology2023

ALK F1174S mutation impairs ALK kinase activity in EML4-ALK variant 1 and sensitizes EML4-ALK variant 3 to crizotinib.

Jikui Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.